Back to results
US 8,273,782 B2Granted
Inhibitors of Akt activity
AssigneeGlaxoSmithKline LLC
InventorsMark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
Life of this patent
Estimating the term…
Abstract
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Claims64
A compound:
- N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide;
- or a pharmaceutically acceptable salt thereof.
A pharmaceutically acceptable salt of the compound:
Dependencies are inferred from the claim text.